Jim Plante is an accomplished entrepreneur and business leader, currently serving as the CEO, Chairman and Founder of Klotho Therapeutics, Inc. He is also known for his previous roles as the Founder and CEO of Pathway Genomics Corporation, and as a Co-Founder, CEO and Seed Investor at E-Band Communications, LLC. With a strong background in investment management and international trade, Mr. Plante has served as a Member of TIGER 21 and as an International Trade Advisory Committee Member at the U.S. Department of Commerce, Economic Development Administration. He has also been a Series A Investor at Fisker Inc, and a Board Trustee at The Biogerontology Research Foundation. He founded Thynk Capital, a private equity firm, as well as the Foundation for Kidney Transplant Research. Mr. Plante was President at Bel-Tronics and has led SmartDrive Systems to success. Jim Plante is a visionary leader in the fields of genetic testing, biotechnology, and healthcare technology, and holds a Bachelor of Science degree in Industrial Engineering from Purdue University.